The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Dose-Response Effect of Elevated Plasma Free Fatty Acid on Insulin Signaling
Open accessAbstract
The dose-response relationship between elevated plasma free fatty acid (FFA) levels and impaired insulin-mediated glucose disposal and insulin signaling was examined in 21 lean, healthy, normal glucose-tolerant subjects. Following a 4-h saline or Liposyn infusion at 30 (n = 9), 60 (n = 6), and 90 (n = 6) ml/h, subjects received a 2-h euglycemic insulin (40 mU · m−2 · min−1) clamp. Basal plasma FFA concentration (∼440 μmol/l) was increased to 695, 1,251, and 1,688 μmol/l after 4 h of Liposyn infusion and resulted in a dose-dependent reduction in insulin-stimulated glucose disposal (Rd) by 22, 30, and 34%, respectively (all P < 0.05 vs. saline control). At the lowest lipid infusion rate (30 ml/h), insulin receptor and insulin receptor substrate (IRS)-1 tyrosine phosphorylation, phosphatidylinositol (PI) 3-kinase activity associated with IRS-1, and Akt serine phosphorylation were all significantly impaired (P < 0.05–0.01). The highest lipid infusion rate (90 ml/h) caused a further significant reduction in all insulin signaling events compared with the low-dose lipid infusion (P < 0.05–0.01) whereas the 60-ml/h lipid infusion caused an intermediate reduction in insulin signaling. However, about two-thirds of the maximal inhibition of insulin-stimulated glucose disposal already occurred at the rather modest increase in plasma FFA induced by the low-dose (30-ml/h) lipid infusion. Insulin-stimulated glucose disposal was inversely correlated with both the plasma FFA concentration after 4 h of lipid infusion (r = −0.50, P = 0.001) and the plasma FFA level during the last 30 min of the insulin clamp (r = −0.54, P < 0.001). PI 3-kinase activity associated with IRS-1 correlated with insulin-stimulated glucose disposal (r = 0.45, P < 0.01) and inversely with both the plasma FFA concentration after 4 h of lipid infusion (r = −0.39, P = 0.01) and during the last 30 min of the insulin clamp (r = −0.43, P < 0.01). In summary, in skeletal muscle of lean, healthy subjects, a progressive increase in plasma FFA causes a dose-dependent inhibition of insulin-stimulated glucose disposal and insulin signaling. The inhibitory effect of plasma FFA was already significant following a rather modest increase in plasma FFA and develops at concentrations that are well within the physiological range (i.e., at plasma FFA levels observed in obesity and type 2 diabetes).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both acute (4 hours) and chronic (4 days) physiologic elevation of plasma FFA concentration in insulin sensitive individuals impairs insulin signaling and causes insulin resistance in skeletal muscle [28, 62–68].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [65]
In the citing paper
“It is well established that chronically elevated plasma FFA levels cause insulin resistance in skeletal muscle [1, 12, 14, 62–65].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [65]
In the citing paper
“The inhibition of insulin signaling and induction of skeletal muscle insulin resistance caused by elevation in the plasma FFA concentration is dose dependent [65].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [65]
In the citing paper
“Such observations are most likely attributed to testosterone-induced changes in lipid metabolism and/or altered postreceptor insulin signaling in muscle (54) and also improved insulin sensitivity enhancing muscle lipid uptake (55).”
From Onset of effects of testosterone treatment and time span until maximum effects are achieved (2011) · cites this paper as [54]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Self-citationRandle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093
Mechanisms of fatty acid-induced inhibition of glucose uptake.
Boden, G., Chen, X., Ruiz, J., White, J. V., & Rossetti, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117252 · Cited by 3,720
DeFronzo, R. A., Jacot, E., Jequier, E., Maeder, E., Wahren, J., & Felber, J. P. (1981) · Diabetes · doi:10.2337/diab.30.12.1000 · Cited by 1,770
Self-citationRole of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728
Yu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J. K., Cushman, S. W., Cooney, G. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200958200 · Cited by 1,561
Mechanism of free fatty acid-induced insulin resistance in humans.
Roden, M., Price, T. B., Perseghin, G., Petersen, K. F., Rothman, D. L., Cline, G. W., & Shulman, G. I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118742 · Cited by 1,539
Lillioja, S., Mott, D. M., Spraul, M., Ferraro, R., Foley, J. E., Ravussin, E., Knowler, W. C., Bennett, P. H., & Bogardus, C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292703 · Cited by 1,508
McGarry, J. D. (2002) · Diabetes · doi:10.2337/diabetes.51.1.7 · Cited by 1,435
Cited by
Sorted by citations
Items 201–300 of 404
Li, X., Kitamura, T., Kawamura, G., Mori, Y., Sato, K., Araki, Y., Sato, R., & Yamada, Y. (2014) · BioScience Trends · doi:10.5582/bst.2014.01060 · Cited by 21
DeFronzo, R. A., Triplitt, & Cersosimo (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s4852 · Cited by 23
Self-citationRadhakutty, A., Mangelsdorf, B. L., Drake, S. M., Samocha‐Bonet, D., Heilbronn, L. K., Smith, M., Thompson, C. H., & Burt, M. G. (2016) · Clinical Endocrinology · doi:10.1111/cen.13138 · Cited by 22
Aguerd, O., Elhrech, H., Fessikh, M. E., Goh, K. W., Omari, N. E., Aanniz, T., & Bouyahya, A. (2025) · Journal of Functional Foods · doi:10.1016/j.jff.2025.106705 · Cited by 24
Razi, O., de Moraes, C., Zamani, N., Saeidi, A., Hadjicharalambous, M., Hackney, A. C., Coso, J. D., Laher, I., & Zouhal, H. (2025) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.70094 · Cited by 24
Sphingolipid regulators of cellular dysfunction in Type 2 diabetes mellitus: a systems overview
Ross, J. S., Russo, S. B., Chavis, G. C., & Cowart, L. A. (2014) · Clinical Lipidology · doi:10.2217/clp.14.37 · Cited by 20
Experimental Hyperlipidemia Dramatically Reduces Access of Insulin to Canine Skeletal Muscle
Chiu, J. D., Kolka, C. M., Richey, J. M., Harrison, L. N., Zuniga, E. A., Kirkman, E. L., & Bergman, R. N. (2009) · Obesity · doi:10.1038/oby.2009.165 · Cited by 20
Li, F., Gao, L., Guan, Q., Hou, X., Wan, Q., Wang, X., & Zhao, J. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0026 · Cited by 20
Cardiovascular Disease and Diabetes
Mangiapane, H. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5441-0_17 · Cited by 20
Sarkar, J., Dwivedi, G., Chen, Q., Sheu, I. E., Paich, M., Chelini, C. M., D'Alessandro, P. M., & Burns, S. P. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192472 · Cited by 21
Insulin Resistance in Type 2 Diabetes
Roden, M., Petersen, K. F., & Shulman, G. I. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch13 · Cited by 20
Brands, M., Hoeks, J., Sauerwein, H. P., Ackermans, M. T., Ouwens, M., Lammers, N. M., van der Plas, M. N., Schrauwen, P., Groen, A. K., & Serlie, M. J. (2011) · Metabolism · doi:10.1016/j.metabol.2011.02.006 · Cited by 19
Ma, Y., Xiong, J., Zhang, X., Qiu, T., Pang, H., Li, X., Zhu, J., Wang, J., Pan, C., Yang, X., et al. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13443 · Cited by 21
Time-course effects of physiological free fatty acid surges on insulin sensitivity in humans
Gormsen, L. C., Nielsen, C., Jessen, N., Jørgensen, J. O. L., & Møller, N. (2010) · Acta Physiologica · doi:10.1111/j.1748-1716.2010.02181.x · Cited by 19
Lifestyle Interventions for Weight Control Modified by Genetic Variation: A Review of the Evidence
Tan, P. Y., Mitra, S. R., & Amini, F. (2018) · Public Health Genomics · doi:10.1159/000499854 · Cited by 19
Lipid-induced insulin resistance does not impair insulin access to skeletal muscle
Kolka, C. M., Richey, J. M., Castro, A. V., Broussard, J. L., Ionut, V., & Bergman, R. N. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00015.2015 · Cited by 20
Grycel, S., Markowski, A. R., Hady, H. R., Zabielski, P., Kojta, I., Imierska, M., Górski, J., & Błachnio-Zabielska, A. U. (2019) · Nutrition · doi:10.1016/j.nut.2019.01.019 · Cited by 18
Isosteviol Has Beneficial Effects on Palmitate-Induced α-Cell Dysfunction and Gene Expression
Chen, X., Hermansen, K., Xiao, J., Bystrup, S., O’Driscoll, L., & Jeppesen, P. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034361 · Cited by 18
Acute effects of elevated NEFA on vascular function: a comparison of SFA and MUFA
Newens, K. J., Thompson, A. K., Jackson, K. G., Wright, J., & Williams, C. M. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114510004976 · Cited by 19
Feng, X., Duan, H., & Li, S. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3070 · Cited by 18
Molonia, M. S., Quesada‐López, T., Speciale, A., Muscarà, C., Saija, A., Villarroya, F., & Cimino, F. (2021) · Chemistry & Biodiversity · doi:10.1002/cbdv.202100607 · Cited by 17
López, S., Bermúdez, B., Pacheco, Y. M., Ortega‐Gómez, A., Varela, L. M., Abia, R., & Muriana, F. J. G. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374420-3.00154-6 · Cited by 17
The Second Meal Effect and Its Influence on Glycemia
Fletcher, J. A. (2012) · Journal of Nutritional Disorders & Therapy · doi:10.4172/2161-0509.1000108 · Cited by 17
Yildirim, V., Sheraton, V. M., Brands, R., Crielaard, L., Quax, R., van Riel, N. A. W., Stronks, K., Nicolaou, M., & Sloot, P. M. A. (2023) · iScience · doi:10.1016/j.isci.2023.108324 · Cited by 18
Friedrichsen, M. H., Poulsen, P., Richter, E. A., Hansen, B. F., Birk, J. B., Ribel‐Madsen, R., Stender-Petersen, K. L., Nilsson, E., Beck‐Nielsen, H., Vaag, A. A., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1795-8 · Cited by 16
Metabolic effects of muraglitazar in type 2 diabetic subjects
Fernandez, M., Gastaldelli, A., Triplitt, C. L., Hardies, J., Casolaro, A., Petz, R., Tantiwong, P., Musi, N., Cersósimo, E., Ferrannini, E., et al. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01429.x · Cited by 16
Self-citationHossain, M. M., Tovar, J., Cloetens, L., Soria-Florido, M. T., Petersson, K., Prothon, F., & Nilsson, A. C. (2021) · Nutrients · doi:10.3390/nu13030988 · Cited by 16
Jebril, M., Liu, X., Shi, Z., Mazidi, M., Altaher, A., & Wang, Y. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17228594 · Cited by 16
The Epidemic of Type 2 Diabetes Mellitus: Its Links to Obesity, Insulin Resistance, and Lipotoxicity
Cusi, K. J. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-260-1_1 · Cited by 15
Self-citationJessen, N., Nielsen, T. S., Vendelbo, M. H., Viggers, R., Støen, O., Evans, A. L., & Fröbert, O. (2016) · Physiological Reports · doi:10.14814/phy2.12781 · Cited by 15
Nonalcoholic Fatty Liver Disease
Puri, P., & Sanyal, A. J. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0881-3.00053-x · Cited by 16
Błachnio-Zabielska, A. U., Roszczyc-Owsiejczuk, K., Imierska, M., Pogodzińska, K., Rogalski, P., Daniluk, J., & Zabielski, P. (2022) · Cells · doi:10.3390/cells11020206 · Cited by 15
Effects of Pollen Typhae total flavone on glucose and lipid metabolism in 3T3-L1 adipocytes
He, Y. (2006) · Journal of Chinese Integrative Medicine · doi:10.3736/jcim20060610 · Cited by 15
Muvhulawa, N., Mazibuko-Mbeje, S. E., Ndwandwe, D. E., Silvestri, S., Ziqubu, K., Moetlediwa, M. T., Mthembu, S. X. H., Marnewick, J. L., van der Westhuizen, F. H., Nkambule, B. B., et al. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122125 · Cited by 16
Kojta, I., Zabielski, P., Roszczyc-Owsiejczuk, K., Imierska, M., Sokołowska, E., & Błachnio-Zabielska, A. U. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197369 · Cited by 14
Frangos, S. M., Bishop, D. J., & Holloway, G. P. (2021) · Biochemical Journal · doi:10.1042/bcj20210145 · Cited by 14
Cersósimo, E., Xu, X., Upala, S., Triplitt, C. L., & Musi, N. (2014) · Physiological Reports · doi:10.14814/phy2.12123 · Cited by 14
Pathogenesis of Type 2 Diabetes Mellitus
DeFronzo, R. A. (2018) · Endocrinology · doi:10.1007/978-3-319-45015-5_8 · Cited by 14
Self-citationOleic acid—the main component of olive oil on postprandial metabolic processes
López, S., Bermúdez, B., la Paz, S. M., Pacheco, Y. M., Ortega‐Gómez, A., Varela, L. M., Lemus‐Conejo, A., Millán-Linares, M. C., Rosillo, M. Á., Abia, R., et al. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819528-4.00034-1 · Cited by 14
Pathogenesis of type 2 diabetes mellitus
DeFronzo, R. A. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch25 · Cited by 17
Self-citationTriglycerides, Glucose Metabolism, and Type 2 Diabetes
Wang, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26209910 · Cited by 20
Zini, E., Osto, M., Konrad, D., Franchini, M., Sieber‐Ruckstuhl, N. S., Kaufmann, K., Guscetti, F., Ackermann, M., Lutz, T. A., & Reusch, C. E. (2010) · Hormone and Metabolic Research · doi:10.1055/s-0030-1248251 · Cited by 13
Acute Free Fatty Acid Elevation Eliminates Endurance Training Effect on Insulin Sensitivity
Chow, L. S., Seaquist, E. R., Eberly, L. E., Mashek, M. T., Schimke, J. M., Nair, K. S., & Mashek, D. G. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1515 · Cited by 13
Newens, K. J., Thompson, A. K., Jackson, K. G., & Williams, C. M. (2015) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2015.03.004 · Cited by 13
Lou, P., Lucchinetti, E., Wawrzyniak, P., Morsy, Y., Wawrzyniak, M., Scharl, M. M., Krämer, S. D., Rogler, G., Hersberger, M., & Zaugg, M. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000412 · Cited by 13
Wang, S., Hu, C., Lin, H., Jia, X., Hu, R., Zheng, R., Li, M., Xu, Y., Xu, M., Zheng, J., et al. (2024) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2024.05.003 · Cited by 12
Effect of Bariatric Weight Loss on the Adipose Lipolytic Transcriptome in Obese Humans
Karki, S., Farb, M. G., Myers, S. J., Apovian, C. M., Hess, D. T., & Gokce, N. (2015) · Mediators of Inflammation · doi:10.1155/2015/106237 · Cited by 12
Insulin Resistance in Type 2 Diabetes
Roden, M., Petersen, K. F., & Shulman, G. I. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch17 · Cited by 14
Yan, C., Burley, G., Gao, H., & Shi, Y. (2025) · Endocrinology · doi:10.1210/endocr/bqaf118 · Cited by 12
Incretin-based therapy: a new horizon in diabetes management
Zarei, M., Vaighan, N. S., Farjoo, M. H., Talebi, S., & Zarei, M. (2024) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-024-01479-3 · Cited by 12
Fu, X., Zhao, Y., Wu, Y., Wen, L., Huo, W., Zhang, D., Zhang, Y., Li, J., Lu, X., Hu, F., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16074 · Cited by 11
Martins, I. J., Creegan, R., Lim, W. L. F., & Martins, R. N. (2013) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2013.35a002 · Cited by 12
Cersósimo, E., Xu, X., Terasawa, T., & Dong, L. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05707-w · Cited by 12
Cincotta, A. H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713255 · Cited by 11
The 6th Annual World Congress on the Insulin Resistance Syndrome
Bloomgarden, Z. T. (2009) · Diabetes Care · doi:10.2337/dc09-zb09 · Cited by 11
Short-term oral exposure to white wine transiently lowers serum free fatty acids
Joosten, M. M., de Graaf, C., Rietman, A., Witkamp, R. F., & Hendriks, H. (2010) · Appetite · doi:10.1016/j.appet.2010.04.217 · Cited by 11
Pathogenesis of Type 2 Diabetes Mellitus
DeFronzo, R. A. (2018) · Endocrinology · doi:10.1007/978-3-319-27317-4_8-1 · Cited by 11
Self-citationSchwanstecher, C., & Schwanstecher, M. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17214-4_1 · Cited by 11
Sasaki, N., Maeda, R., Ozono, R., Nakano, Y., & Higashi, Y. (2021) · Clinical Obesity · doi:10.1111/cob.12496 · Cited by 10
Sasaki, N., Maeda, R., Ozono, R., Yoshimura, K., Nakano, Y., & Higashi, Y. (2022) · Diabetes Care · doi:10.2337/dc21-2554 · Cited by 11
The beneficial impact of curcumin on cardiac lipotoxicity
Abolfazli, S., Butler, A. E., Kesharwani, P., & Sahebkar, A. (2024) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgae102 · Cited by 10
Lipotoxicity in Obesity: Benefit of Olive Oil
Saad, E., Sbeit, W., Luai, A., Massad, B., & Assy, N. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-48382-5_26 · Cited by 11
Samkani, A., Skytte, M. J., Anholm, C., Astrup, A. V., Deacon, C. F., Holst, J. J., Madsbad, S., Boston, R., Krarup, T., & Haugaard, S. B. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0953-8 · Cited by 11
Obesity: Molecular Mechanisms, Epidemiology, Complications and Pharmacotherapy
Jaberi, S. A., Cohen, A., Saeed, Z., Ojha, S. K., Singh, J., & Adeghate, E. A. (2021) · Advances in biochemistry in health and disease · doi:10.1007/978-3-030-84763-0_13 · Cited by 10
Metabolic Syndrome in Preeclampsia Women in Gorgan
Marjani, A., Rafeeinia, A., Tabandeh, A., & Khajeniazi, S. (2014) · The Open Biochemistry Journal · doi:10.2174/1874091x01408010094 · Cited by 10
Role of Mitochondrial Function in Insulin Resistance
Brands, M., Verhoeven, A. J., & Serlie, M. J. M. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-2869-1_9 · Cited by 9
Glaesser, D., & Iwig, M. (2024) · Experimental Eye Research · doi:10.1016/j.exer.2024.109888 · Cited by 9
Ikeoka, D., Pachler, C., Mader, J. K., Bock, G., Neves, A. L., Švehlíková, E., Feichtner, F., Koehler, G., Wrighton, C. J., Pieber, T. R., et al. (2010) · Obesity · doi:10.1038/oby.2010.227 · Cited by 9
Fatty acids may influence insulin dynamics through modulation of albumin‐Zn2+ interactions
Arya, S., Gourley, A. J., Penedo, J. C., Blindauer, C. A., & Stewart, A. J. (2021) · BioEssays · doi:10.1002/bies.202100172 · Cited by 9
Norton, L., Parr, T., Chokkalingam, K., BARDSLEY, R. G., Ye, H. J., Bell, G. I., Pelsers, M. M. A. L., van Loon, L. J. C., & Tsintzas, K. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1981 · Cited by 9
Chen, M. Z., Hudson, C. A., Vincent, E. E., de Berker, D. A. R., May, M., Hers, I., Dayan, C. M., Andrews, R. C., & Tavaré, J. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120084 · Cited by 9
Metabolische Nebenwirkungen von Antipsychotika der neuen Generation
Engl, J., Tschoner, A., Laimer, M. W., Rettenbacher, M. A., Fleischhacker, W. W., Patsch, J. R., & Ebenbichler, C. F. (2006) · Wiener klinische Wochenschrift · doi:10.1007/s00508-006-0584-3 · Cited by 10
Acipimox Acutely Increases GLP-1 Concentrations in Overweight Subjects and Hypopituitary Patients
Vestergaard, E. T., Hjelholt, A. J., Kuhre, R. E., Møller, N., Larraufie, P., Gribble, F. M., Reimann, F. M., Jessen, N., Holst, J. J., & Jørgensen, J. O. L. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02503 · Cited by 9
Differential Roles of CD36 in Regulating Muscle Insulin Response Depend on Palmitic Acid Load
Sun, J.-Y., Su, Y.-J., Chen, J., Qin, D., Xu, Y., Chu, H., Lu, T.-F., Dong, J., Qin, L.-L., & Li, W.-D. (2023) · Biomedicines · doi:10.3390/biomedicines11030729 · Cited by 5
Palmitate exacerbates bisphenol A toxicity via induction of ER stress and mitochondrial dysfunction
Mondal, A., Burchat, N., & Sampath, H. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158816 · Cited by 8
Cardiac Metabolism in Health and Disease
Opie, L. H. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405206-2.00002-8 · Cited by 8
Role of Dietary Macronutrients and Fatty Acids in Obesity and Metabolic Risk in Older Adults
Dooley, C., & Ryan, A. S. (2019) · International Journal of Obesity and Nutritional Science · doi:10.18689/ijons-1000102 · Cited by 7
Association of Ratio of Apolipoprotein B to Apolipoprotein A1 With Survival in Peritoneal Dialysis
Yu, J., Xia, X., Huang, N., Qiu, Y., Yang, X., Mao, H., Chen, W., & Huang, F. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.801979 · Cited by 7
(2012) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/978160805361211201010039 · Cited by 7
Regulation of Intermediatory Metabolism During Fasting and Feeding
DeFronzo, R. A., & Ferrannini, E. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00036-8 · Cited by 7
Self-citationBlüher, M., & Stümvoll, M. (2020) · Endocrinology · doi:10.1007/978-3-030-36694-0_1 · Cited by 10
Síndrome de Berardinelli-Seip: descrição genética e metabólica de cinco pacientes
Barra, C., Savoldelli, R. D., Manna, T. D., Kim, C. A., Magre, J., Porta, G., Setian, N., & Damiani, D. (2011) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302011000100007 · Cited by 7
Consequences of Dicarbonyl Stress on Skeletal Muscle Proteins in Type 2 Diabetes
Ahmad, K., Shaikh, S., Lee, E. J., Lee, Y., & Choi, I. (2019) · Current Protein and Peptide Science · doi:10.2174/1389203720666191119100759 · Cited by 7
Nakamura, N., Tokunaga, D. S., Ha, H. Y., & Polgár, N. (2022) · Cells · doi:10.3390/cells11152440 · Cited by 7
Zhyzhneuskaya, S. V., & Taylor, R. (2017) · Endocrinology · doi:10.1007/978-3-319-47685-8_21-1 · Cited by 8
Gonzalez, J. T., Lolli, L., Veasey, R. C., Rumbold, P. L. S., Betts, J. A., Atkinson, G., & Stevenson, E. (2024) · European Journal of Nutrition · doi:10.1007/s00394-024-03467-y · Cited by 8
Martínez‐Hervás, S., Navarro, I., Real, J. T., Artero, A., Peiró, M., Navarro, H. G., Carmena, R., & Ascaso, J. F. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161400 · Cited by 6
Short‐term acipimox treatment is associated with decreased cardiac parasympathetic modulation
Vestergaard, E. T., Cichosz, S. L., Møller, N., Jørgensen, J. O. L., & Fleischer, J. (2017) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13384 · Cited by 6
Effects of Sustained Hyperglycemia on Skeletal Muscle Lipids in Healthy Subjects
Shannon, C. E., Merovci, A., Fourcaudot, M. J., Tripathy, D., Abdul‐Ghani, M. A., Wang, H., Han, X., Norton, L., & DeFronzo, R. A. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac306 · Cited by 7
Self-citationHandy, R. M., DesOrmeaux, G. J., Barbeau, P., Frangos, S. M., & Holloway, G. P. (2023) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00196.2022 · Cited by 6
The Mediterranean food pattern: a good recipe for patients with the metabolic syndrome
Amezaga, C. A. V.-D., Zulet, M. Á., Martí, A., Martínez‐González, M. Á., & Martínez, J. A. (2008) · Mediterranean Journal of Nutrition and Metabolism · doi:10.1007/s12349-008-0001-8 · Cited by 6
Ciechanowska, A., Ładyżyński, P., Wojcicki, J. M., Sabalińska, S., Krzymień, J., Pulawska, E., Karnafel, W., Foltyński, P., & Kawiak, J. (2013) · The International Journal of Artificial Organs · doi:10.5301/ijao.5000265 · Cited by 6
Cao, Y., Xu, R., & Zhang, J. (2026) · Frontiers in Pediatrics · doi:10.3389/fped.2026.1679527 · Cited by 5
3D Bioprinted Fat‐Myocardium Model Unravels the Role of Adipocyte Hypertrophy in Atrial Dysfunction
Celebi, L. E., & Zorlutuna, P. (2026) · Advanced Science · doi:10.1002/advs.202516114 · Cited by 5
Wismayer, D. S., LAURENTI, M. C., Song, Y., Egan, A. M., Welch, A. A., Bailey, K. R., Cobelli, C., Man, C. D., Jensen, M. D., & Vella, A. V. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00043.2023 · Cited by 5
Basic Concepts in Insulin Resistance and Diabetes Treatment
Bril, F., & Cusi, K. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-72475-1_3 · Cited by 5
Self-citationMoreno‐Pérez, B., Benito, E., Civera, M., Alabadí, B., Martínez‐Hervás, S., Peiró, M., Navarro, H. G., Piqueras, L., Sanz, M., Ascaso, J. F., et al. (2020) · International Journal of Clinical Practice · doi:10.1111/ijcp.13776 · Cited by 4
Pathophysiology and Management of Dyslipidemias Associated with Insulin-Resistant States
Maki, K. C., Benes, L. B., & Dicklin, M. R. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-56514-5_16 · Cited by 6
Pathogenesis of Insulin Resistance
Zaman, G. S. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.92864 · Cited by 6
Sieber‐Ruckstuhl, N. S., Zini, E., Osto, M., Franchini, M., Boretti, F. S., Meli, M. L., Sigrist, B., Lutz, T. A., & Reusch, C. E. (2010) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2010.06.003 · Cited by 5
Metadata
- Authors
- Belfort, R., Mandarino, L., Kashyap, S., Wirfel, K., Pratipanawatr, T., Berria, R., DeFronzo, R. A., & Cusi, K.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2005-06-01
- Volume
- 54
- Issue
- 6
- Pages
- 1640-1648
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2115433418
- Cited by
- 404
- References
- 74
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 22 · 2023: 10 · 2022: 18 · 2021: 21 · 2020: 24 · 2019: 15 · 2018: 14 · 2017: 20 · 2016: 15 · 2015: 23 · 2014: 28 · 2013: 26 · 2012: 15
- FWCI
- 11.03
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK-24092, F32DK061189, R01DK024092)
- National Center for Research Resources (M01RR01346, M01RR001346)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- plasma free fatty acids, insulin signaling, insulin resistance, insulin-stimulated glucose disposal, dose-response relationship, insulin receptor tyrosine phosphorylation, IRS-1, phosphatidylinositol 3-kinase, hyperinsulinemic-euglycemic clamp
- MeSH terms
- Adult, Dose-Response Relationship, Drug, Emulsions, Fat Emulsions, Intravenous, Fatty Acids, Nonesterified, Female, Glucose, Humans, Insulin, Male, Safflower Oil, Soybean Oil, Signal Transduction, Muscle, Skeletal, Lecithins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review